BALCX | CBDYX | BALCX / CBDYX | |
Total Expense Ratio | 1.31 | 0.60 | 218% |
Annual Report Gross Expense Ratio | 1.31 | 0.60 | 218% |
Fund Existence | 25 years | 13 years | - |
Gain YTD | 10.835 | 10.034 | 108% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 259B | 10.1B | 2,564% |
Annual Yield % from dividends | 1.16 | 1.89 | 61% |
Returns for 1 year | 9.12 | 6.91 | 132% |
Returns for 3 years | 37.20 | 36.99 | 101% |
Returns for 5 years | 35.50 | 28.76 | 123% |
Returns for 10 years | 67.85 | 75.46 | 90% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EMBD | 23.73 | 0.22 | +0.94% |
Global X Emerging Markets Bond ETF | |||
BBRE | 95.66 | 0.85 | +0.90% |
JPMorgan BetaBuilders MSCI US REIT ETF | |||
ITDC | 33.29 | 0.09 | +0.26% |
iShares LifePath Target Date 2035 ETF | |||
NBGX | 27.48 | N/A | N/A |
Neuberger Berman Growth ETF | |||
MSTZ | 5.07 | -0.27 | -5.06% |
T-REX 2X Inverse MSTR Daily Target ETF |